| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 09/03/2008 | CN100415769C Oligomeric or polymerized methylene protein separation and purification process |
| 09/03/2008 | CN100415292C New class of bioactive glycoprotein |
| 09/02/2008 | US7420035 Attaching to matrix via cyclizing with aldehyde or ketone groups (capture tags), washing, then releasing |
| 08/28/2008 | US20080207873 Biosynethetic gene cluster for jerangolids |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207488 Removal of conformational altered protein; side effect reduction |
| 08/28/2008 | US20080207485 Major histocompatibility complex with peptide binding grooves; controlling oligomerization |
| 08/28/2008 | US20080206885 Environmentally sensitive fluorophores |
| 08/28/2008 | US20080206838 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 08/28/2008 | US20080206406 Modified Proteins With Altered Aggregation Properties |
| 08/28/2008 | US20080206271 Contains a binding ligand, a Pseudomonas exotoxin A translocation domain II, an antigenic moiety, and a carboxyl terminal moiety which binds to the endoplasmic reticulum of the target T-cells, B-cells, dendritic cells, monocytes, or macrophages; inoculation |
| 08/28/2008 | US20080206264 when bound by a highly potent human neutralizing monoclonal antibody specific for a V3 conformational epitope; immunogens for inducing broadly-neutralizing antibodies against HIV-1 as well as antagonists for inhibiting the binding of HIV-1 to the relevant co-receptors |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206182 biocompatible hydroxyalkyl starch, dextran or polyethylene glycol polymers functionalized by an aminooxy group; improved circulatory life time in vivo; reduced antigenicity and immunogenicity of the proteins; therapeutic proteins such as EPO, G-CSF, Factor VII, Factor IX, IFN beta, AT III, A1AT, Factor V |
| 08/28/2008 | US20080206160 Antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and antiinflammatory properties; preventing and reversing skin surface damage; wound healing include abrasions, blisters, burns, lacerations, ulcers, bruises, rashes, scars, and the effects of aging |
| 08/27/2008 | CN101250218A Method for preparing cod collagen |
| 08/26/2008 | US7417028 Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions |
| 08/21/2008 | WO2007106476A3 Compositions and methods for enhancing the immunogenicity of antigens |
| 08/21/2008 | US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
| 08/21/2008 | US20080200645 Methods for Treatment or Prophylaxis of Atherosclerosis and Reperfusion Injury |
| 08/21/2008 | US20080200644 Method for inverse solid phase synthesis of peptides |
| 08/21/2008 | US20080200533 Creating modified complex molecules having reduced toxicity and enhanced bioavailability; such as reaction product of atorvastatin and 2,6-diaminohexanoic acid; increasing solubility; reducing dosage levels |
| 08/21/2008 | US20080200428 Antiproliferative Drug |
| 08/21/2008 | US20080200368 Peptide composition |
| 08/21/2008 | US20080200366 Modulating melanocortin receptors |
| 08/21/2008 | US20080199934 Adding functional groups to peptides for use in preparation of muscle and silk protein |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199439 Displaces inhibitor of apoptosis proteins (IAP) from caspase; modification of light emission when bound to cell; selectively damages or kills neoplastic cells |
| 08/21/2008 | US20080199436 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 08/21/2008 | US20080199426 Administering compound which inhibits tie-1 protein, thrombin, growth factors; increases activity of nitric oxide synthase; arteriosclerosis, sepsis, rheumatoid arthritis and pre-eclampsia |
| 08/20/2008 | EP1958960A2 A process for the preparation of a non-toxic anthrax vaccine |
| 08/20/2008 | EP1644402B1 Arginine/lysine-enriched peptides |
| 08/20/2008 | CN100412086C Glycopeptide compositions |
| 08/19/2008 | US7414023 polypeptides/peptidomimetics; solid phase synthesis; for use in diagnositc assays |
| 08/14/2008 | WO2006107617A3 Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| 08/14/2008 | US20080194459 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 08/14/2008 | US20080193762 Water soluble metal and semiconductor nanoparticle complexes |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/13/2008 | EP1956085A2 Carbohydrate crosslinked glycoprotein crystals |
| 08/13/2008 | EP1954299A1 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
| 08/13/2008 | CN101240015A Core-peptide composition with physiological activity and its preparation method and application |
| 08/13/2008 | CN101240014A Lipopeptid composition with physiological activity and its preparation method and application |
| 08/07/2008 | WO2006107786A3 Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
| 08/07/2008 | US20080188641 Methods for detecting and inhibiting angiogenesis |
| 08/07/2008 | US20080188413 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 08/07/2008 | US20080188401 Compounds |
| 08/07/2008 | US20080188399 Drug-Polymer Conjugates Coupled to a Peptidic Carrier |
| 08/07/2008 | US20080187530 Novel Agents and Use Thereof |
| 08/07/2008 | US20080187491 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 08/05/2008 | US7408023 Joining spacer to biopolymers; generate spacer, join to bioplymer, recover biopolymer; conjugation that can be carried out entirely in the solid phase, with minimal disruption to automated synthetic protocols |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 08/05/2008 | US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying |
| 07/31/2008 | US20080182969 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 07/31/2008 | US20080182968 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 07/31/2008 | US20080182294 Recombinant clostridial neurotoxins (botulinum) having functional binding, translocation, and therapeutic domains; also an amino acid sequence susceptible to specific cleavage by proteases in vitro following expression as a single chain; inserts; therapeutic agents, transporter molecules; drug delivery |
| 07/31/2008 | US20080182275 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/31/2008 | US20080181909 Chimeric immunomodulatory compounds and methods of using the same |
| 07/30/2008 | CN101230087A Technique for producing hirudin by using poecilobdella manillensis frozen fresh body as raw material |
| 07/30/2008 | CN101230086A Technique for producing hirudin by using poecilobdella manillensis saliva as raw material |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2273071C Method for ligating oligopeptides |
| 07/29/2008 | CA2203033C Compounds and compositions for delivering active agents |
| 07/24/2008 | WO2008088548A2 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | WO2007121184A3 Compounds and methods for diagnosis and treatment of leishmaniasis |
| 07/24/2008 | US20080177040 Alkaline protease |
| 07/24/2008 | US20080177028 Plant PR-5 proteins as mammalian therapeutic agents |
| 07/24/2008 | US20080177027 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses |
| 07/24/2008 | US20080177026 Bacterial polypeptide for use in diagnosis, prevetntion and treatment of microorganismal infection; immunotherapy |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 07/24/2008 | US20080175855 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 07/24/2008 | US20080175854 Point mutations; antibodies; fusion proteins |
| 07/24/2008 | US20080175798 Peptide-based hair protectants |
| 07/23/2008 | EP1945655A2 Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof in particular for therapeutic purposes |
| 07/23/2008 | CN101225105A Miscellaneous fish enzymolysis polypeptide and uses thereof |
| 07/22/2008 | US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family |
| 07/22/2008 | US7402652 Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders |
| 07/22/2008 | US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines |
| 07/17/2008 | WO2008085191A1 Polypeptide inhibitors of hsp27 kinase and uses therefor |
| 07/17/2008 | US20080171848 Using tris(hydroxymethyl)aminomethane buffering agent in purification of glucagon-like peptides |
| 07/17/2008 | US20080171693 Such as Survivn; antiproliferative, antitumor agents; apoptosis; a polypeptide peptidomimetic that includes the amino acid sequence His-Ser-Ser-Gly-Cys |
| 07/17/2008 | CA2689296A1 Polypeptide inhibitors of hsp27 kinase and uses therefor |
| 07/16/2008 | EP1944610A1 Engineering affinity ligands for macromolecules |
| 07/16/2008 | EP1942947A2 Fibronectin polypeptides and methods of use |
| 07/15/2008 | US7399745 polypeptides, fragments and/or variants, used for treatment of metabolic disorders, such as diabetes and obesity; hypoglycemic agents |
| 07/15/2008 | CA2144473C Pna synthesis using a base-labile amino protecting group |
| 07/10/2008 | US20080168583 Nucleic acid molecules and other molecules associated with plants |
| 07/10/2008 | US20080168574 Nucleotide sequences coding tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | US20080167443 Novel chelating agents and highly luminescent and stable chelates and their use |
| 07/10/2008 | US20080167386 Anticarcinogenic and antiproliferative agents; drug screening; inhibiting Dvl-mediated Wnt signaling |
| 07/10/2008 | US20080166730 Therapeutic and diagnostic proteins comprising a SOCS box |
| 07/10/2008 | US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/10/2008 | DE102007043859A1 Mineralisierte Polypeptidsubstanz für den Knochenaufbau und deren Herstellung Mineralized Polypeptidsubstanz for bone formation and their preparation |
| 07/09/2008 | EP1940442A2 Phosphorylation of tau by abl |
| 07/09/2008 | CN101215322A Artificial antigen and antibody of furazolidone metabolite 3-amino-2-oxazolidone and preparation method thereof |
| 07/08/2008 | US7396906 Pro4399 Polypeptides |
| 07/08/2008 | US7396682 Genetic engineered protein; joining mammals cells |
| 07/08/2008 | CA2250712C Chimeric isoprenoid synthases and uses thereof |